Phase I and Pharmacologic Study of Irinotecan Administered as a 96-Hour Infusion Weekly to Adult Cancer Patients
TAKIMOTO, C. H, MORRISON, G, ISMAIL, A. S, FLEMMING, D, GOSKY, D. M, HIROTA, H, BERGER, S. J, BERGER, N. A, CHEN, A. P, SHAPIRO, J. D, ARBUCK, S. G, WRIGHT, J, HAROLD, N, HAMILTON, J. M, ALLEGRA, C. J, GREM, J. L, QUINN, M, MONAHAN, B. P, BAND, R. A, COTTRELL, J, GUEMEI, A, LLORENS, V, HEHMAN, H
Published in Journal of clinical oncology (01.02.2000)
Published in Journal of clinical oncology (01.02.2000)
Get full text
Journal Article
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity : correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan
GUEMEI, Aida A, COTTRELL, Jeff, TAKIMOTO, Chris H, BAND, Roger, HEHMAN, Hilary, PRUDHOMME, Mike, PAVLOV, Michael V, GREM, Jean L, ABDEL SALAM ISMAIL, BOWEN, Donnell, TAYLOR, Robert E
Published in Cancer chemotherapy and pharmacology (01.04.2001)
Published in Cancer chemotherapy and pharmacology (01.04.2001)
Get full text
Journal Article